Succinate: A metabolic signal in inflammation

Trends in Cell Biology

Volumn 24, Issue 5, 2014, Pages 313-320

  Mills, Evanna ^a   O'Neill, Luke A J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

HIF 1 ; Inflammation; Metabolism; Succinate; Succinylation; SUCNR1

Indexed keywords

AUTACOID; G PROTEIN COUPLED RECEPTOR; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SUCCINIC ACID;

ADAPTIVE IMMUNITY; ANIMAL; CITRIC ACID CYCLE; HUMAN; INFLAMMATION; INNATE IMMUNITY; METABOLISM; PHYSIOLOGY; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

ADAPTIVE IMMUNITY; ANIMALS; CITRIC ACID CYCLE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNITY, INNATE; INFLAMMATION; INFLAMMATION MEDIATORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SUCCINIC ACID;

EID: 84899473768     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2013.11.008     Document Type: Review

References (50)

1. Janeway C.A., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 2002, 20:197-216.
2. Pearce E.L., Pearce E.J. Metabolic pathways in immune cell activation and quiescence. Immunity 2013, 38:633-643.
3. Krawczyk C.M., et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 2010, 115:4742-4749.
4. Tannahill G.M., et al. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature 2013, 496:238-242.
5. Everts B., et al. Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood 2012, 120:1422-1431.
6. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
7. Dang E.V., et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 2011, 146:772-784.
8. Rubic T., et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat. Immunol. 2008, 9:1261-1269.
9. McGettrick A.F., O'Neill L.A. How metabolism generates signals during innate immunity and inflammation. J. Biol. Chem. 2013, 288:22893-22898.
10. Infantino V., et al. The mitochondrial citrate carrier: a new player in inflammation. Biochem. J. 2011, 438:433-436.
11. He W., et al. Mitochondrial sirtuins: regulators of protein acylation and metabolism. Trends Endocrinol. Metab. 2012, 23:467-476.
12. Liu T.F., McCall C.E. Deacetylation by SIRT1 reprograms inflammation and cancer. Genes Cancer 2013, 4:135-147.
13. Yeung F., et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004, 23:2369-2380.
14. Zhang R., et al. SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages. J. Biol. Chem. 2010, 285:7097-7110.
15. Lim J.H., et al. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol. Cell 2010, 38:864-878.
16. Levine B., et al. Autophagy in immunity and inflammation. Nature 2011, 469:323-335.
17. +/NADH ratio and SIRT1 protein activation. J. Biol. Chem. 2012, 287:19304-19314.
18. Lee I.H., et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3374-3379.
19. Lin J., et al. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 2005, 1:361-370.
20. Misawa T., et al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat. Immunol. 2013, 14:454-460.
21. Schug T.T., et al. Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress. Mol. Cell. Biol. 2010, 30:4712-4721.
22. Tannahill G.M., O'Neill L.A. The emerging role of metabolic regulation in the functioning of Toll-like receptors and the NOD-like receptor Nlrp3. FEBS Lett. 2011, 585:1568-1572.
23. Guzy R.D., et al. Loss of the SdhB, but not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis. Mol. Cell. Biol. 2008, 28:718-731.
24. Kietzmann T., Gorlach A. Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin. Cell Dev. Biol. 2005, 16:474-486.
25. Hollander A.P., et al. Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum. 2001, 44:1540-1544.
26. Wobben R., et al. Role of hypoxia inducible factor-1alpha for interferon synthesis in mouse dendritic cells. Biol. Chem. 2013, 394:495-505.
27. He W., et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 2004, 429:188-193.
28. Wittenberger T., et al. An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors. J. Mol. Biol. 2001, 307:799-813.
29. Ariza A.C., et al. The succinate receptor as a novel therapeutic target for oxidative and metabolic stress-related conditions. Front. Endocrinol. 2012, 3:22.
30. Robben J.H., et al. Localization of the succinate receptor in the distal nephron and its signaling in polarized MDCK cells. Kidney Int. 2009, 76:1258-1267.
31. Bhuniya D., et al. Discovery of a potent and selective small molecule hGPR91 antagonist. Bioorg. Med. Chem. Lett. 2011, 21:3596-3602.
32. Park J., et al. SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol. Cell 2013, 50:919-930.
33. Zhang Z., et al. Identification of lysine succinylation as a new post-translational modification. Nat. Chem. Biol. 2011, 7:58-63.
34. Du J., et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 2011, 334:806-809.
35. Nakagawa T., et al. SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 2009, 137:560-570.
36. Hawkins B.J., et al. Mitochondrial complex II prevents hypoxic but not calcium- and proapoptotic Bcl-2 protein-induced mitochondrial membrane potential loss. J. Biol. Chem. 2010, 285:26494-26505.
37. Wayne L.G., Lin K.Y. Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions. Infect. Immun. 1982, 37:1042-1049.
38. Eoh H., Rhee K.Y. Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:6554-6559.
39. McKinney J.D., et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 2000, 406:735-738.
40. Cimen H., et al. Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria. Biochemistry 2010, 49:304-311.
41. McGivney A., Bradley S.G. Action of bacterial endotoxin and lipid A on mitochondrial enzyme activities of cells in culture and subcellular fractions. Infect. Immun. 1979, 25:664-671.
42. Wu W., Zhao S. Metabolic changes in cancer: beyond the Warburg effect. Acta Biochim. Biophys. Sin. 2013, 45:18-26.
43. Selak M.A., et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 2005, 7:77-85.
44. Maxwell P.H., et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999, 399:271-275.
45. 2+ transient and cardiomyocyte viability through PKA-dependent pathway. Cell Calcium 2010, 47:37-46.
46. Oeckinghaus A., et al. Crosstalk in NF-kappaB signaling pathways. Nat. Immunol. 2011, 12:695-708.
47. Toma I., et al. Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J. Clin. Invest. 2008, 118:2526-2534.
48. Ghanem F.A., Movahed A. Inflammation in high blood pressure: a clinician perspective. J. Am. Soc. Hypertens. 2007, 1:113-119.
49. Sadagopan N., et al. Circulating succinate is elevated in rodent models of hypertension and metabolic disease. Am. J. Hypertens. 2007, 20:1209-1215.
50. Fukui S., et al. Mucosal blood flow and generation of superoxide in rat experimental colitis induced by succinic acid. J. Gastroenterol. 1997, 32:464-471.